AGP Picks
View all

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on June 1, 2026

Neurosurgeon Dr. Nizam Razack Brings Problem-Solving Approach to Congressional Race
Steve and Gina Merritt and The This Is It Team 'Lead Road To Unstoppable Tour' as Global Momentum Builds
Precious Hearts Launches At-Home Protocol to Help Small-Dog Owners Manage Heart Disease
Nxera’s Vamorolone Granted Key Regulatory Designations Supporting Faster Access for Duchenne Muscular Dystrophy Patients in South Korea
SafeSpace Global Expands AI-powered Physical Safety Footprint Through Successful Integration with 911inform, the Nation's Leading Emergency Response Platform
PROMINENT FLORIDA BUSINESS LEADER BRETT KINGSTONE ENDORSES DR. NIZAM RAZACK FOR UNITED STATES CONGRESS
Rakovina Therapeutics Announces Q1 2026 Financial Results and Provides Corporate Update
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026
University of Miami Miller School of Medicine Names Dr. Pradeep Ramulu Chair of Ophthalmology and the Bascom Palmer Eye Institute
Teva to Present at the Goldman Sachs Global Healthcare Conference
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CorVel Appoints Sarah Scott CEO and President; Michael G. Combs to Transition to Executive Chair
Praxis Precision Medicines Provides Vormatrigine Program Update
UroGen Pharma to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis
Abivax annonce des résultats majeurs de l’essai de maintenance de phase 3 ABTECT évaluant l’obéfazimod dans le traitement de la rectocolite hémorragique active modérée à sévère
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs

Share this page:

Sign up for:

Florida Health Daily

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.